Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)

NCT00005777 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

220

Enrollment

NETWORK

Sponsor class

Stopped The trial was halted because of unanticipated nonrespiratory adverse events related to dexamethasone therapy.

Conditions

Bronchopulmonary Dysplasia
Respiratory Distress Syndrome
Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Infant, Premature

Interventions

PROCEDURE: Minimal mechanical ventilation management
PROCEDURE: Routine mechanical ventilation management
DRUG: Dexamethasone
DRUG: Placebo

Sponsor

NICHD Neonatal Research Network

Collaborators

[object Object]